Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: open-label comparison of randomized treatment with estradiol …
W Junge, V El-Samalouti, C Gerlinger… - European Journal of …, 2009 - Elsevier
OBJECTIVES: Clinical studies have reported changes in hemostatic parameters in women
taking menopausal hormone therapy (HT) and a small increased risk of venous …
taking menopausal hormone therapy (HT) and a small increased risk of venous …
The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodene
N Fuchs, B Düsterberg, F Weber-Diehl, B Mühe - Contraception, 1995 - Elsevier
To obtain an overview of the effect of monophasic gestodene on blood pressure and to
determine the frequency of “OC elevated BP/hypertension,” the results of blood pressure …
determine the frequency of “OC elevated BP/hypertension,” the results of blood pressure …
Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control
D Apter, Y Zimmerman, L Beekman… - … European Journal of …, 2017 - Taylor & Francis
Objectives: This study evaluated acceptability, user satisfaction, body weight control and
general well-being of estetrol (E4) combined with either drospirenone (DRSP) or …
general well-being of estetrol (E4) combined with either drospirenone (DRSP) or …
Low thrombin generation in users of a contraceptive containing estetrol and drospirenone
L Morimont, M Jost, U Gaspard… - The Journal of …, 2023 - academic.oup.com
Objective To compare the impact on thrombin generation of the new combined oral
contraceptive containing 15 mg estetrol and 3 mg drospirenone with ethinylestradiol (30 or …
contraceptive containing 15 mg estetrol and 3 mg drospirenone with ethinylestradiol (30 or …
A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or …
JM Foidart, W Wuttke, GM Bouw… - … European Journal of …, 2000 - Taylor & Francis
Objective To assess the contraceptive reliability, cycle control and tolerance of a new
monophasic oral contraceptive (Yasmin®) containing 30 μg ethinylestradiol and 3 mg …
monophasic oral contraceptive (Yasmin®) containing 30 μg ethinylestradiol and 3 mg …
Effect of a continuous regimen of contraceptive combination of ethinylestradiol and drospirenone on lipid, carbohydrate and coagulation profiles
RB Machado, NR de Melo, H Maia Jr, AM Cruz - Contraception, 2010 - Elsevier
BACKGROUND: The objective of this study was to evaluate the effects of a contraceptive pill
containing ethinylestradiol (30 mcg) and drospirenone (3 mg) in a continuous regimen on …
containing ethinylestradiol (30 mcg) and drospirenone (3 mg) in a continuous regimen on …
Comparative trial of the effects on glucose tolerance and lipoprotein metabolism of two new oral contraceptives containing gestoden and desogestrel
KR Petersen, SO Skouby, A Dreisler… - Acta obstetricia et …, 1988 - Taylor & Francis
The effects of two new low-dose oral contraceptives (triphasic ethinyl estradiollgestoden and
monophasic ethinyl estradiolldesogestrel) on glucose tolerance, plasma insulin response to …
monophasic ethinyl estradiolldesogestrel) on glucose tolerance, plasma insulin response to …
Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability
DF Archer, HJ Ahrendt, D Drouin - Contraception, 2015 - Elsevier
Objectives This study was performed to assess the contraceptive efficacy of the
drospirenone (DRSP)-only pill and to provide information regarding its safety and cycle …
drospirenone (DRSP)-only pill and to provide information regarding its safety and cycle …
Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled …
C Klipping, I Duijkers, MP Fortier, J Marr… - Journal of Family …, 2012 - srh.bmj.com
Background The contraceptive efficacy and tolerability of a new flexible extended regimen of
ethinylestradiol (EE) 20 μg/drospirenone (DRSP) 3 mg to extend the menstrual cycle and …
ethinylestradiol (EE) 20 μg/drospirenone (DRSP) 3 mg to extend the menstrual cycle and …
Effects of two contraceptives containing drospirenone on blood pressure in normotensive women: a randomized-controlled trial
MN de Nadai, F Nobre, RA Ferriani… - Blood Pressure …, 2015 - journals.lww.com
Objective Drospirenone (DRSP) is a progestogen derived from spironolactone with
antimineralocorticoid action that seems to exert a favorable effect on blood pressure (BP); …
antimineralocorticoid action that seems to exert a favorable effect on blood pressure (BP); …